The estimated Net Worth of Horacio Plotkin is at least $106 Thousand dollars as of 12 December 2014. Horacio Plotkin owns over 2,100 units of Retrophin stock worth over $6,424 and over the last 12 years Horacio sold RTRX stock worth over $99,727.
Horacio has made over 3 trades of the Retrophin stock since 2013, according to the Form 4 filled with the SEC. Most recently Horacio sold 2,100 units of RTRX stock worth $21,147 on 12 December 2014.
The largest trade Horacio's ever made was selling 8,333 units of Retrophin stock on 17 November 2014 worth over $78,580. On average, Horacio trades about 2,106 units every 81 days since 2013. As of 12 December 2014 Horacio still owns at least 91,767 units of Retrophin stock.
You can see the complete history of Horacio Plotkin stock trades at the bottom of the page.
Horacio's mailing address filed with the SEC is C/O RETROPHIN, INC., 777 THIRD AVENUE, 22ND FLOOR, NEW YORK, NY, 10017.
Over the last 12 years, insiders at Retrophin have traded over $26,547,782 worth of Retrophin stock and bought 585,006 units worth $5,991,663 . The most active insiders traders include Martin Shkreli, Ron Squarer, and Steve Aselage. On average, Retrophin executives and independent directors trade stock every 23 days with the average trade being worth of $1,651. The most recent stock trade was executed by Laura Clague on 23 November 2020, trading 7,500 units of RTRX stock currently worth $174,675.
Retrophin, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. Its products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, CA.
Retrophin executives and other stock owners filed with the SEC include: